Welcome to the e-CCO Library!

P462: Long-term outcomes of anti-TNF therapy discontinuation in patients with penetrating Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Gompertz M., Ricart E., Ordás I., Alfaro I., Lόpez A., Gallego M., Barastegui R., Giner A., Vara A., Masamunt M., Panés J.

Created: Wednesday, 20 February 2019, 10:36 AM
P462: Mucosal healing and deep remission rates with azathioprine in inflammatory bowel disease?
Year: 2018
Source: ECCO '18 Vienna
Authors:

Ü. Dağlı*, D. Özer Etik, N. Demir, S. Öcal, H. Selçuk, F. Hilmioğlu, S. Boyacıoğlu

Created: Thursday, 21 February 2019, 9:14 AM
P462: Upfront infliximab dose intensification for secondary loss of response in IBD: similar efficacy to dose interval shortening with the added advantage of early clinical and pharmacokinetic predictors of response
Year: 2022
Source: ECCO'22
Authors: Srinivasan, A.(1,2,3);De Cruz, P.(3,4);Sam, M.(5,6,7);Toong, C.(5,6,7,8);van Langenberg, D.(1,2);
Created: Friday, 11 February 2022, 3:52 PM
P463 Induction of endoscopic response: a network meta-analysis of induction studies comparing ontamalimab with other treatments for moderate-to-severe ulcerative colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Vickers1, A. Nag2, B. Devine3, B.E. Sands4, R. Panaccione5, L. Peyrin-Biroulet6, S. Danese7, S. Vermeire8, K.J. Gorelick9, M. Goetsch10, L. Hartley1

Created: Thursday, 30 January 2020, 10:12 AM
P463: Combination therapy of fresh faecal microbial transplantation and antibiotics for ulcerative colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

D. Ishikawa*, T. Osada, K. Haga, T. Kodani, T. Shibuya, S. Watanabe

Created: Friday, 22 February 2019, 9:49 AM
P463: COVID-19 vaccination willingness and hesitancy in patients with Inflammatory Bowel Diseases (IBD): analysis of determinants in a national survey of the Italian IBD patients’ association (AMICI Onlus).
Year: 2021
Source: ECCO'21 Virtual
Authors: Costantino, A.(1);Noviello, D.(2);Conforti, F.S.(1);Aloi, M.(3);Armuzzi, A.(4);Bossa, F.(5);Ficari, F.(6);Leone, S.(7);Manguso, F.(8);Mocci, G.(9);Orlando, A.(10);Pironi, L.(11);Radice, S.(12);Rizzello, F.(13);Tongiorgi, A.(14);Costantino, C.(15);Vecchi, M.(1,2);Caprioli, F.(1,2);
Created: Wednesday, 2 June 2021, 4:12 PM
P463: Crohn's disease–associated anorectal cancer has a poor prognosis with high local recurrence: a subanalysis of the Nationwide Japanese Study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Ogino, T.(1,2)*;Mizushima, T.(2);Sekido, Y.(1);Fujii, M.(3);Eguchi, H.(1);Nezu, R.(4);Ikeuchi, H.(5);Uchino, M.(5);Futami, K.(6);Okamoto, K.(7);Ajioka, Y.(8);Sugihara, K.(9);Ishihara, S.(10);
Created: Friday, 14 July 2023, 11:05 AM
P463: Factors to determine prognosis of intestinal cancer associated with Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Shinozaki*1, R. Takahashi1

Created: Friday, 22 February 2019, 9:41 AM
P463: Long-term effects of anti-TNF therapy on bone metabolism
Year: 2018
Source: ECCO '18 Vienna
Authors:

N. O'Morain1*, G. Farrell1, M. Hanly1, S. Veerappan1, D. McNamara1,2, N. Breslin1, C. O'Morain2, M. Healy3, B. Ryan1,2

Created: Thursday, 21 February 2019, 9:14 AM
P463: Recurrence of Crohn's disease after the first surgical intervention
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Pontes García A.1, Gallardo Valverde J.M.*2, Iglesias Flores E.3, García Sanchez V.3, Díaz Lόpez C.2, Martínez Dueñas J.L.2, Medina J.2, Navarro E.2, Torres E.2, Gόmez Barbadillo J.2

Created: Wednesday, 20 February 2019, 10:36 AM
P463: Serum and mucosal Serpin E1 concentration correlates with endoscopic activity in inflammatory bowel disease - potential new activity marker
Year: 2022
Source: ECCO'22
Authors: Jójárt, B.(1);Molnár, T.(2);Kata, D.(3);Szabó, V.(1);Varga, Á.(1);Resál, T.(4);Bacsúr, P.(4);Szántó, K.(4);Földesi, I.(3);Molnár, T.(4);Maléth, J.(1);Farkas, K.(4);
Created: Friday, 11 February 2022, 3:52 PM
P464 Vedolizumab concentrations in colonic mucosal tissue of ulcerative colitis patients inversely correlate with the severity of inflammation
Year: 2020
Source:

ECCO'20 Vienna

Authors:

N. Van den Berghe1, B. Verstockt2,3, A. Gils1, M. Ferrante2,3, S. Vermeire2,3, D. Thomas1

Created: Thursday, 30 January 2020, 10:12 AM
P464: Assessing medication adherence in patients with inflammatory bowel disease: what do we choose, self-adherence scales or pharmacy rates?
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. L. De Castro*1, L. Sanromán1, A. Martín2, N. Martínez2, M. Figueira1, V. Hernández1, J. R. Pineda1, J. Martínez-Cadilla1, S. Pereira1, V. Del Campo3, J.-I. Rodríguez-Prada1

Created: Friday, 22 February 2019, 9:49 AM
P464: Effects of ozanimod on histologic remission and mucosal healing over 3 years of continuous treatment in patients with ulcerative colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Panaccione, R.(1)*;Danese, S.(2);Wolf, D.C.(3);Canavan, J.B.(4);Jain, A.(4);Wu, H.(4);Petersen, A.(4);Afzali, A.(5);Abreu, M.T.(6);
Created: Friday, 14 July 2023, 11:05 AM
P464: Rac1/pSTAT3 expression in T lymphocytes: A potential pharmacodynamic marker for thiopurines in the treatment of Inflammatory Bowel Disease patients?
Year: 2022
Source: ECCO'22
Authors: DebenMSc, D.(1);Creemers, R.(2,3);Van Adrichem, A.(4);Drent, R.(5);Merry, A.(6);Leers, M.(5);Van Bodegraven, A.(2,7);Wong, D.(1);
Created: Friday, 11 February 2022, 3:52 PM
P464: Recurrence of ulcerative colitis during pregnancy in patients who became pregnant during remission
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ito A.*1, Murasugi S.2, Kashiwagi H.2, Hara T.2, Omori T.1, Yonezawa M.1, Iizuka B.1, Tokushige K.2

Created: Wednesday, 20 February 2019, 10:36 AM
P464: Steroid dependency in patients with Ulcerative Colitis treated with advanced therapies in a German real-world-setting
Year: 2021
Source: ECCO'21 Virtual
Authors: Bokemeyer, B.(1);Picker, N.(2);Wilke, T.(3);Rosin, L.(4);Patel, H.(5);
Created: Wednesday, 2 June 2021, 4:12 PM
P464: Study of the usual aetiologies of methotrexate and azathioprine discontinuation in inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Skamnelos*1, K. Katsanos1, D. Christodoulou1

Created: Friday, 22 February 2019, 9:41 AM
P464: Switching from the originator infliximab to biosimilar CT-P13 did not change the quality of life and clinical efficacy for IBD patients in stable remission in daily clinical practice (interim analysis)
Year: 2018
Source: ECCO '18 Vienna
Authors:

M.J. Pierik1, A.E. van der Meulen-de Jong2, J.P.J. Bloemsaat-Minekus3*, Y.J.B. van Megen3, G. Dijkstra4

Created: Thursday, 21 February 2019, 9:14 AM
P465 Therapeutic drug monitoring in Crohn’s disease patients, a comparison between homogeneous mobility shift assay and point of care method
Year: 2020
Source:

ECCO'20 Vienna

Authors:

G. Bodini1, M.G. Demarzo1, A. Djahandideh1, I. Baldissarro1, E. Savarino2, V. Savarino3, A. Jain4, P.M. Risso3, E.G. Giannini3

Created: Thursday, 30 January 2020, 10:12 AM